Last reviewed · How we verify

NCT03441685

Strategies for Teaching Verbs

Completed NA Results posted Last updated 7 June 2024
What this trial tests

NA trial testing Semantic cues (perform action), syntactic cues (sentence frame), or combined semantic and syntactic cues in Language Development Disorders in 44 participants. Completed in 2 July 2021.

Timeline
21 March 2018
Primary endpoint
2 July 2021
2 July 2021

Quick facts

Lead sponsorVanderbilt University Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment44
Start date21 March 2018
Primary completion2 July 2021
Estimated completion2 July 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 3 to 17, any sex, with Language Development Disorders or Down Syndrome. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Accuracy Identifying Taught Words - Syntactic Condition Primary · From date of initial evaluation to focused intervention session, up to 1 month

Participants are asked to receptively identify novel verbs taught in syntactic condition by selecting the video of the named verb from a field of two. Participants were asked to identify each of the 4 taught words per condition 3 times for a total of 12 trials per condition. This "receptive probe" has a minimum score of 0 and maximum of 12. Higher scores indicate a better outcome.

GroupValue95% CI
Typical Development8.73± 3.26
Down Syndrome8.75± 3.11
Developmental Language Disorder10.29± 2.21
Accuracy Identifying Taught Words - Semantic Condition Primary · From date of initial evaluation to focused intervention session, up to 1 month

Participants are asked to receptively identify novel verbs taught in semantic condition by selecting the video of the named verb from a field of two. Participants were asked to identify each of the 4 taught words per condition 3 times for a total of 12 trials per condition. This "receptive probe" has a minimum score of 0 and maximum of 12. Higher scores indicate a better outcome.

GroupValue95% CI
Typical Development8.91± 3.54
Down Syndrome9.50± 2.93
Developmental Language Disorder10.14± 2.67
Accuracy Identifying Taught Words - Combined Condition Primary · From date of initial evaluation to focused intervention session, up to 1 month

Participants are asked to receptively identify novel verbs taught in combined condition by selecting the video of the named verb from a field of two. Participants were asked to identify each of the 4 taught words per condition 3 times for a total of 12 trials per condition. This "receptive probe" has a minimum score of 0 and maximum of 12. Higher scores indicate a better outcome.

GroupValue95% CI
Typical Development9.04± 2.75
Down Syndrome9.38± 2.07
Developmental Language Disorder10.00± 2.24
Accuracy Labeling Taught Words - Syntactic Condition Secondary · From date of initial evaluation to focused intervention session, up to 1 month

After the teaching episodes for the syntactic condition participants are asked to label novel verbs expressively. Participants were asked to label each of the 4 taught words per condition one time for a total of 4 trials per condition. This "expressive probe" has a minimum score of 0 and maximum of 4. Higher scores indicate a better outcome.

GroupValue95% CI
Typical Development0.61± 0.58
Down Syndrome0.75± 0.71
Developmental Language Disorder0.86± 0.90
Accuracy Labeling Taught Words - Semantic Condition Secondary · From date of initial evaluation to focused intervention session, up to 1 month

After the teaching episodes for the semantic condition participants are asked to label novel verbs expressively. Participants were asked to label each of the 4 taught words per condition one time for a total of 4 trials per condition. This "expressive probe" has a minimum score of 0 and maximum of 4. Higher scores indicate a better outcome.

GroupValue95% CI
Typical Development0.52± 0.73
Down Syndrome1.00± 0.93
Developmental Language Disorder0.43± 0.79
Accuracy Labeling Taught Words - Combined Condition Secondary · From date of initial evaluation to focused intervention session, up to 1 month

After the teaching episodes for the combined condition participants are asked to label novel verbs expressively. Participants were asked to label each of the 4 taught words per condition one time for a total of 4 trials per condition. This "expressive probe" has a minimum score of 0 and maximum of 4. Higher scores indicate a better outcome

GroupValue95% CI
Typical Development0.70± 0.63
Down Syndrome1.38± 1.41
Developmental Language Disorder0.71± 1.11

Sponsor's own description

This study is designed to evaluate whether children with Down syndrome and children with typical development exhibit different levels of accuracy demonstrating novel verbs taught under three conditions: semantic cues (perform action), syntactic cues (sentence frame), and combined (syntactic and semantic cues). The participants complete an eligibility evaluation and then one verb learning session (approximately 60 minutes in length). During that verb learning session they are taught sets of words under each condition (i.e., within-subjects design) and then asked to identify and label those target words immediately after instruction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Language Development Disorders

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03441685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing